Saladaga, Roselyn M.

HRN: 10-15-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
CEFTRIAXONE 1G (VIAL)
10/29/2022
11/05/2022
IV
2g
OD
Increased Wbc
Waiting Final Action 
10/31/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2022
11/10/2022
IV
4.5g
Q6h
Hypoxic Enceph
Waiting Final Action 
11/01/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
11/01/2022
11/07/2022
IV
750mg
OD
CAP-HR
Waiting Final Action 
11/03/2022
LEVOFLOXACIN 500MG (TAB)
11/03/2022
11/19/2022
PO
500mg
OD
CAP-HR
Waiting Final Action 
11/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2022
11/09/2022
IVT
4.5g
Q6
Sepsis, CAP-HR, Hypoxic Encephalopathy
Waiting Final Action 
11/10/2022
LEVOFLOXACIN 500MG (TAB)
11/10/2022
11/13/2022
ORAL
500mg
OD
CAP HR With Aspiration Component
Waiting Final Action 
11/19/2022
MUPIROCIN 2%, 15G (TUBE)
11/19/2022
11/25/2022
TOPICAL
1 Squirt
BID
Bed Sores
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: